Synergy Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-529
Closed -$129K 679
2024
Q4
$129K Buy
+529
New +$127K 0.01% 219
2024
Q3
Sell
-2,068
Closed -$396K 173
2024
Q2
$396K Sell
2,068
-70,679
-97% -$14.3M 0.06% 97
2024
Q1
$14.4M Buy
72,747
+3,364
+5% +$616K 2.45% 13
2023
Q4
$11.9M Buy
69,383
+15,663
+29% +$2.41M 2.14% 19
2023
Q3
$7.94M Buy
+53,720
New +$9.71M 1.57% 21
2022
Q2
Sell
-27,963
Closed -$6.78M 126
2022
Q1
$6.78M Sell
27,963
-7,182
-20% -$1.74M 1.63% 24
2021
Q4
$9.15M Buy
+35,145
New +$9.12M 2.18% 17

Other funds holding RMD

Synergy Asset Management's RMD Position: Q1 2025 in Review

Synergy Asset Management sold out of ResMed (RMD) in Q1 2025, closing a stake of 529 shares — an estimated $129K sold.

Synergy Asset Management first reported a position in RMD in Q4 2021 and held it in 7 quarters. The position peaked at $14.4M in Q1 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Synergy Asset Management reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Synergy Asset Management sold 529 ResMed shares in Q1 2025, an estimated $129K.
  • Synergy Asset Management first reported a position in ResMed in Q4 2021 and held it in 7 quarters.
  • Synergy Asset Management's ResMed position peaked at $14.4M in Q1 2024.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Synergy Asset Management's 13F filing for Q1 2025, filed 22 Apr 2025.